[Cu64]DOTATATE
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for [Cu64]DOTATATE, covering 2022-12-22 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE [Phase 4]